The PE Ratio as of December 2025 (TTM) for Corcept Therapeutics Incorporated (0I3Q.L) is 92.89

According to Corcept Therapeutics Incorporated’s latest financial reports and current stock price. The company's current PE Ratio is 92.89. This represents a change of 4.67% compared to the average of 88.74 of the last 4 quarters.

Corcept Therapeutics Incorporated (0I3Q.L) Historical PE Ratio (quarterly & annually)

How has 0I3Q.L PE Ratio performed in the past?

The mean historical PE Ratio of Corcept Therapeutics Incorporated over the last ten years is 20.76. The current 92.89 PE Ratio has changed 44.65% with respect to the historical average. Over the past ten years (40 quarters), 0I3Q.L's PE Ratio was at its highest in in the June 2016 quarter at 153.73. The PE Ratio was at its lowest in in the March 2016 quarter at -6752.81.

Corcept Therapeutics Incorporated (0I3Q.L) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Corcept Therapeutics Incorporated PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Corcept Therapeutics Incorporated (0I3Q.L) Average PE Ratio

How has 0I3Q.L PE Ratio performed in the past?

The current PE Ratio of Corcept Therapeutics Incorporated (0I3Q.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Corcept Therapeutics Incorporated (0I3Q.L) PE Ratio vs. Peers

How is 0I3Q.L’s PE Ratio compared to its peers?

Corcept Therapeutics Incorporated’s PE Ratio is greater than Halozyme Therapeutics, Inc. (13.26), greater than Masimo Corporation (-12.71), greater than Axsome Therapeutics, Inc. (-33.27), greater than Henry Schein, Inc. (24.24), greater than Exelixis, Inc. (17.54), greater than DaVita Inc. (10.76), greater than TG Therapeutics, Inc. (75.19), greater than BioMarin Pharmaceutical Inc. (22.56), greater than Viking Therapeutics, Inc. (-16.65), greater than Baxter International Inc. (-28.58),

Build a custom stock screener for Corcept Therapeutics Incorporated (0I3Q.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corcept Therapeutics Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corcept Therapeutics Incorporated (0I3Q.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corcept Therapeutics Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.